UAE Genetic Testing Market (By Technology: Next-generation Sequencing, Array Technology; By Application; By Channel; By End-use) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on UAE Genetic Testing Market 

5.1. COVID-19 Landscape: UAE Genetic Testing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global UAE Genetic Testing Market, By Technology Type

8.1. UAE Genetic Testing Market, by Technology Type, 2024-2033

8.1.1. Next Generation Sequencing

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Array Technology - Specific to Microarray Only

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. PCR-based Testing

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. FISH

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global UAE Genetic Testing Market, By Application Type

9.1. UAE Genetic Testing Market, by Application Type e, 2024-2033

9.1.1. Ancestry & Ethnicity

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Cancer Screening

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Genetic Disease Carrier Status

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. New Baby Screening

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Traits

9.1.5.1. Market Revenue and Forecast (2021-2033)

9.1.6. Health and Wellness - Predisposition/ Risk / Tendency

9.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global UAE Genetic Testing Market, By Channel 

10.1. UAE Genetic Testing Market, by Channel, 2024-2033

10.1.1. Online (Own Website/ App, Aggregators, Marketplace)

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Offline (Pharmacy, Own Clinics, Partner Clinics, Lab, Hospitals)

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.2. Others

10.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global UAE Genetic Testing Market, By End-use 

11.1. UAE Genetic Testing Market, by End-use, 2024-2033

11.1.1. Hospitals & Clinics

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Diagnostic Laboratories

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global UAE Genetic Testing Market, Regional Estimates and Trend Forecast

12.1. UAE

12.1.1. Market Revenue and Forecast, by Technology Type (2021-2033)

12.1.2. Market Revenue and Forecast, by Application Type (2021-2033)

12.1.3. Market Revenue and Forecast, by Channel (2021-2033)

12.1.4. Market Revenue and Forecast, by End-use (2021-2033)

Chapter 13. Company Profiles

13.1. Middle East Testing Services L.L.C

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Molecular Biology & Genetics Laboratory

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. NSG

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Freiburg Medical Laboratory Middle East

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. IVI MIDDLE EAST FERTILITY CLINIC

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. 23andMe, Inc

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Ancestry

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. CircleDNA

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. 24Genetics

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. MyDNA Life Australia Pty Ltd.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms